PyInvesting

Market research

0A3.F Acceleron Pharma Inc

F EUR Real Estate

Latest close

7.72 —

As of Nov 18, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
5B
P/E ratio
10.36
Analyst target
Not available
Dividend yield
7.3%
Beta
0.39

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Acceleron Pharma Inc is currently in a long term downtrend where the price is trading 2.7% below its 200 day moving average.

From a valuation standpoint, the stock is 93.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 82.1.

Acceleron Pharma Inc's total revenue sank by 34.2% to $26M since the same quarter in the previous year.

Its net income has dropped by 143.5% to $-57M since the same quarter in the previous year.

Finally, its free cash flow fell by 124.7% to $-39M since the same quarter in the previous year.

Based on the above factors, Acceleron Pharma Inc gets an overall score of 1/5.